The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
OMDA · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | STE | PEN | OMDA | AATC |
|---|---|---|---|---|
| Moat Score (0–100) | 65 (highest) | 65 (highest) | 65 (highest) | 65 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 93 (highest) | 90 | 70 | 44 |
| Pricing power | 73 | 100 (highest) | 95 | 97 |
| Returns on capital | 16 | 4 | — | 55 (highest) |
| Balance-sheet safety | 82 | 73 | 55 | 100 (highest) |
| Capital discipline | 60 (highest) | 60 (highest) | 39 | 27 |
| Price vs. high estimate | 99% above high estimate | 6707% above high estimate | No price data | 13% above high estimate (largest discount to high estimate) |
| Market cap | $20.9B | $12.5B | $1.2B | $29.6M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filings as of | FY2026 | FY2025 | FY2025 | FY2021 |